Full-Time
Mobile Phlebotomist
Confirmed live in the last 24 hours
Getlabs
51-200 employees
At-home diagnostics and mobile phlebotomy services
Compensation Overview
$28/hr
Junior
San Francisco, CA, USA
- Phlebotomy certification from an accredited agency
- 1 year of phlebotomy experience (mobile phlebotomy experience preferred)
- Experience processing samples
- Certification from a national agency such as American Medical Technologists (AMT), American Society for Clinical Pathology (ASCP), or National Center for Competency Testing (NCCT)
- Proven track record in providing exceptional customer service
- Strong communication skills; both written and verbal
- Ability to drive in the dark - first appointments may be as early as 5am!
- Ability to physically access patients including but not limited to kneeling, bending, stooping, sitting and reaching
- Ability to physically navigate patients homes including but not limited to climbing stairs and carrying 15 pounds while walking
- Ability to work independently or in a team environment under minimal supervision
- Reliable transportation and clean driving record
- Proof of first shot of Covid-19 Vaccine by 30 days of employment
- Visit patients in their home or office, drive to and from appointments, drop samples off at patient service centers or laboratories
- Follow safe and accurate blood collection procedures and processing of specimens, with a high degree of accuracy
- Maintain close communication with the operations and patient experience team during business hours
- Bonus Qualifications: Fluent in Spanish
Getlabs provides at-home diagnostic services by connecting healthcare organizations with mobile phlebotomists who visit patients' homes to collect lab samples, vital signs, and perform advanced diagnostics. The process allows patients to receive necessary medical tests without needing to travel to a clinic or hospital. Getlabs stands out from competitors by offering same-day service across the country, which helps improve patient adherence to medical recommendations and addresses gaps in care. The company's goal is to enhance access to diagnostic services, ultimately aiming to save lives by making healthcare more accessible.
Company Size
51-200
Company Stage
Series A
Total Funding
$24M
Headquarters
Miami, Florida
Founded
2018
Simplify's Take
What believers are saying
- Growing demand for telehealth services supports Getlabs' at-home diagnostic model.
- Increased investment in digital health startups boosts Getlabs' expansion potential.
- Partnerships with genomic testing companies enhance Getlabs' service depth and patient insights.
What critics are saying
- Competition from companies like Everlywell and LetsGetChecked threatens Getlabs' market share.
- Rapid telehealth advancements may require Getlabs to invest heavily in technology upgrades.
- Data privacy concerns could arise from handling sensitive patient information in partnerships.
What makes Getlabs unique
- Getlabs offers at-home diagnostic collections, enhancing convenience and accessibility for patients.
- Partnerships with companies like Inocras and Nice Healthcare expand Getlabs' service offerings.
- Getlabs' one-tap API simplifies integration for healthcare organizations, streamlining service delivery.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Paid Vacation
Medical, dental and vision insurance options
Stock Options
Mileage reimbursement
Growth & Insights and Company News
6 month growth
↓ -5%1 year growth
↓ -5%2 year growth
↓ -8%MIAMI, April, 24, 2024 /PRNewswire/ -- Getlabs , the nationwide leader in at-home diagnostics collection, has joined forces with Inocras , a leading AI-driven whole genome testing company that empowers patients with critical genetic insights for cancer and rare diseases.Getlabs' mission is to save lives by delivering outstanding healthcare to everyone. The company has redesigned the lab experience around patients, allowing them to book lab sample collections conveniently and comfortably from their homes, creating greater accessibility and convenience in their care process.Inocras provides whole genome sequencing tests, which deliver patients deep insights into their cancer and rare disease by providing comprehensive and detailed analyses of an individual's genetic composition. The company's innovative digital service platform offers patients a seamless end-to-end experience, allowing them to request a test order, book at-home sample collections with the help of the Getlabs partnership, and receive test results with genetic counseling support.By embedding Getlabs' at-home lab collection services within Inocras's intuitive end-to-end patient testing process, this partnership promises a unique and enhanced experience for patients, who will benefit from its convenience and efficiency."We are thrilled to embark on this partnership with Inocras," said Kyle Michelson, CEO of Getlabs. "Together, we are empowering patients to take control of their health journey by providing them with access to lab collection services without having to travel to or sit in a waiting room."Inocras Chief Strategy Officer, Rebecca Jang, remarks, "We are thrilled to launch our whole genome diagnostics products, CancerVision and RareVision. They will provide a more holistic view on patients' disease and health, presenting not only commonly known mutations but also ultra rare and complicated mutations. Patients can get cutting-edge diagnostics through our patient-centric digital service platform
Getlabs, the largest nationwide provider for at-home diagnostic collections, has partnered with Fountain TRT, a leading provider of testosterone replacement therapy (TRT) for men, to offer convenient at-home hormone testing and treatment.
In-home diagnostics leader Getlabs and in-home primary care clinic Nice Healthcare join forces to make healthcare more accessible.MIAMI, May 2, 2023 /PRNewswire/ -- Getlabs, the leading provider of at-home diagnostic collections, has partnered with Nice Healthcare , an in-home and virtual primary care clinic, to expand access to in-home healthcare services and lab testing. The partnership is expected to help improve access to these services, making it easier and more convenient for people to get the care they need.Getlabs has been at the forefront of at-home diagnostics, offering patients access to over 5,000 lab tests from the comfort of their homes and offices. With this partnership, Nice Healthcare patients can benefit from a more convenient and comprehensive suite of diagnostic tests."At Getlabs, our mission is to save lives by delivering outstanding healthcare to everyone," said Kyle Michelson, CEO of Getlabs. "We're excited to partner with Nice Healthcare to expand access to virtual healthcare services and at-home diagnostics. We believe that together, we can provide patients with an unparalleled level of convenience, quality, and affordability.""Nice Healthcare is excited to partner with Getlabs to expand our in-home healthcare services and broaden access to lab testing services," said Genvieve Swenson, FNP-C, Cofounder and COO of Nice Healthcare. "We believe that Getlabs' vast network of at-home lab testing services and our in-home and virtual primary care clinic will provide patients with a more personalized and cost-effective healthcare experience
Additionally, Sonora Quest Laboratories recently partnered with Getlabs to provide at-home blood tests, as well as in-car tests to reduce patient’s exposure to COVID.
Biosynthetic Technologies, an Indianapolis IN-based biotechnology company, raised USD 7.5M in Series A-1 funding.